Analyst Research

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: Finlabo SIM Spa
$10.00
Provider: MarketLine (a Datamonitor Company)
$175.00
Provider: GlobalData
$125.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Fresenius SE & Co KGaA raises FY 2014 sales outlook; confirms FY 2014 net income guidance


Wednesday, 30 Jul 2014 08:00pm EDT 

Fresenius SE & Co KGaA:Raises its FY 2014 sales outlook following acquisitions at Fresenius Medical Care, and expects sales to increase by 14 pct to 16 pct in constant currency.Says previously, it expected sales growth of 12 pct to 15 pct.Confirms fully FY 2014 net income guidance, and continues to expect increase of 2 pct to 5 pct in constant currency. 

Company Quote

50.76
0.24 +0.48%
30 Jan 2015